In a first-of-its-kind clinical trial, physician-scientists are exploring a new method to potentially prevent recurrence of an early stage, aggressive type of breast cancer.
The pilot study, conducted by Joe Baar, MD, Professor, Division of Hematology Oncology, Director of Breast Cancer Research at UH Case Medical Center’s Seidman Cancer Center, is recruiting patients with HER-2 neu+ breast cancer. “This study has the potential to change the standard of care for women with this type of breast cancer, which tends to spread very quickly,” says Dr. Baar, who is also Associate Professor of Medicine at Case Western Reserve University School of Medicine.
Read the full article :: Medical News Today
